N/A
N=38
Effects of Inspiratory Muscle Training in Patients With Bronchiectasis
Bronchiectasis
Bottom Line
View on ClinicalTrials.gov: NCT00952718 ↗Enrolled (actual)
38
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcome: Primary: Maximum Inspiratory Pressure (MIP) and Maximum Expiratory Pressure (MEP) at 8 Weeks — 60; 71; 84; 69 cmH2O — p=0.005
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Inspiratory muscle training (Other)
- Age
- Adult, Older Adult · 40+ yrs
- Sex
- All
- Sponsor
- Chang Gung Memorial Hospital
- Primary completion
- Dec 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Maximum Inspiratory Pressure (MIP) and Maximum Expiratory Pressure (MEP) at 8 Weeks |
60; 71; 84; 69; 72; 76 | 0.005 sig |
| SECONDARY Six Minutes Walking Distance |
427; 411; 447; 473 | 0.063 |
| SECONDARY 6 Minute Work |
20140; 21052; 22457; 23915 | 0.269 |
Summary
The purpose of this study is to determine whether inspiratory muscle training could improve and/or prevent the deterioration of inspiratory muscle strength, clinical cardiopulmonary outcome, systemic immunologic responses and quality of life in patients with bronchiectasis.
Eligibility Criteria
Inclusion Criteria
- Bronchiectasis confirmed by clinical history, pulmonary function test, and high resolution computed tomography
Exclusion Criteria
- Had recent exacerbation within six weeks
- Use of corticosteroid
- With poor consciousness level
- Have cerebro-vascular or neuro-muscular disorders
Data sourced from ClinicalTrials.gov (NCT00952718). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.